National Storage Mechanism | Additional information
RNS Number : 0918Q
Societe Generale SA
16 June 2020
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BYPERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.       KEY INFORMATION

 

Name of person dealing (Note 1)

Société Générale S.A.

Company dealt in

               Willis Towers Watson plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

15/06/2020

 

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

256,488

0.20

8,307

0.01

(2) Derivatives (other than options)

88

0.00

12,345

0.01

(3) Options and agreements to purchase/sell

0

0.00

0

0.00

Total

*1,360,783

*1.06

20,652

0.02

                               

* Include the holding of 1,104,207 shares on borrow products

 

               

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 

Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

 

 

 

 

(2) Derivatives (other than options)

 

 

 

 

(3) Options and agreements to purchase/sell

 

 

 

 

Total

 

 

 

 

 

 

Ap20

 

 

1.       DEALINGS (Note 4)

 

(a)      Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit USD (Note 5)

Purchase

20

189.65

Purchase

80

189.65

Purchase

32

189.36

Purchase

1

185.232

Purchase

1

184.622

Purchase

1

186.212

Purchase

1

186.382

Purchase

1

182.272

Purchase

1

185.912

Purchase

1

185.762

Purchase

1

185.272

Purchase

1

185.722

Purchase

1

185.742

Purchase

50

190.09

Purchase

21

190.09

Purchase

22

190.09

Purchase

2

190.09

Purchase

5

190.09

Purchase

100

189.36

Purchase

619

189.36

Purchase

1,078

189.36

Sale

232

181.57

Sale

116

181.57

Sale

77

181.57

Sale

77

181.57

Sale

45

185.87

Sale

5

185.87

Sale

2

185.87

Sale

2

185.87

Sale

38

185.87

Sale

6

185.87

Sale

2

185.87

Sale

25

185.58

Sale

75

185.58

Sale

86

186.14

Sale

100

184.78

Sale

14

186.13

Sale

100

186.22

Sale

100

190.01

Sale

100

187.54

Sale

100

187.45

Sale

100

187.45

Sale

100

185.02

Sale

100

184.75

Sale

100

190.16

Sale

92

186.29

Sale

100

187.47

Sale

100

187.47

Sale

50

186.13

Sale

100

184.93

Sale

75

185.4

Sale

25

185.39

Sale

80

186.48

Sale

20

186.46

Sale

21

185.12

Sale

69

185.12

Sale

10

185.12

Sale

90

185.87

Sale

10

185.87

Sale

91

186.32

Sale

9

186.32

Sale

17

185.37

Sale

71

185.37

Sale

4

185.37

Sale

8

185.37

Total Purchases

2,039

 

Total Sales

2,744

 

 

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit USD

(Note 5)

 

 

 

 

 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

 

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and 

any other person relating to the voting rights of any relevant securities under any option referred to 

on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to 

which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)                                            No

 

Date of disclosure

16/06/2020

Contact name

Société Générale - Disclosure team

Telephone number

+33 1 42 14 92 74

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEFIFFDRTIRLII